Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures
ClinicalTrials.gov study NCT00448539. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and Metabolites
ClinicalTrials.gov study NCT02169427. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets
ClinicalTrials.gov study NCT01922739. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
ClinicalTrials.gov study NCT02955940. IPD Sharing: YES. Countries: 2. Publications: 0.
An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma
ClinicalTrials.gov study NCT02648997. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
ClinicalTrials.gov study NCT00765856. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (P
ClinicalTrials.gov study NCT06675864. IPD Sharing: YES. Countries: 7. Publications: 0.
An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expande
ClinicalTrials.gov study NCT01595009. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
ClinicalTrials.gov study NCT01931033. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
ClinicalTrials.gov study NCT00730171. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 40
ClinicalTrials.gov study NCT00000649. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis
ClinicalTrials.gov study NCT03911869. IPD Sharing: YES. Countries: 5. Publications: 0.
An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome
ClinicalTrials.gov study NCT00701311. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label, Multiple-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093
ClinicalTrials.gov study NCT02281526. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label, Adaptive, Parallel Group PET Study Using RO7017773 And [11C] RO15-4513
ClinicalTrials.gov study NCT03507569. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT01453205. IPD Sharing: Not stated. Countries: 11. Publications: 0.
An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)
ClinicalTrials.gov study NCT04950764. IPD Sharing: NO. Countries: 4. Publications: 0.
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
ClinicalTrials.gov study NCT05939414. IPD Sharing: YES. Countries: 26. Publications: 0.
Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT01408576. IPD Sharing: Not stated. Countries: 25. Publications: 0.
STEM-PD Open Label Extension (OLE)
ClinicalTrials.gov study NCT04799418. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.